Identification of tumor microenvironment‑associated immunological genes as potent prognostic markers in the cancer genome analysis project HOPE

Project High‑tech Omics‑based Patient Evaluation (HOPE), which used whole‑exome sequencing and gene expression profiling, was launched in 2014. A total of ~2,000 patients were enrolled until March 2016, and the survival time was observed up to July 2019. In our previous study, a tumor microenvironment immune type classification based on the expression levels of the programmed death‑ligand 1 (PD‑L1) and CD8B genes was performed based on four...